Status quo of research on HGFc-Met signaling pathway in cancers.
10.3760/cma.j.issn.0253-3766.2013.05.001
- Author:
Hui-ling SU
1
;
Feng-ling LIU
;
Tong HAO
Author Information
1. Email: 16263266@qq.com.
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal;
therapeutic use;
Antineoplastic Agents;
therapeutic use;
Drug Resistance, Neoplasm;
Humans;
Mutation;
Neoplasms;
metabolism;
therapy;
Polymorphism, Single Nucleotide;
Proto-Oncogene Proteins c-met;
antagonists & inhibitors;
genetics;
metabolism;
Signal Transduction
- From:
Chinese Journal of Oncology
2013;35(5):321-324
- CountryChina
- Language:Chinese
